Adma Biologics (ADMA) Change in Acquisitions & Divestments (2016 - 2017)

Adma Biologics (ADMA) posted Change in Acquisitions & Divestments of $245000.0 for Q2 2017, down 95.24% on a QoQ basis from $5.1 million in Q1 2017, and up 106.67% year-over-year from $118546.5 in Q2 2016.

Adma Biologics (ADMA) Change in Acquisitions & Divestments (2016 - 2017) Analysis & Trends

Adma Biologics' Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $245000.0 for Q2 2017.

  • Quarterly Change in Acquisitions & Divestments rose 106.67% year-over-year to $245000.0 in Q2 2017, while the trailing twelve-month figure through Mar 2018 was $245000.0 (down 98.65% YoY) and the FY2017 annual result came in at $5.4 million, down 67.64% from the prior year.
  • Change in Acquisitions & Divestments was $245000.0 for Q2 2017 at Adma Biologics, down from $5.1 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $16.7 million in Q4 2016 and bottomed at -$3.7 million in Q2 2016.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Adma Biologics 1.98 Bn 1.89 Bn 88.82 Mn

Historic Data

Download Data
DateValue
Jun 30, 2017 245,000.00
Jun 30, 2017 245,000.00
Mar 31, 2017 5.15 Mn
Mar 31, 2017 5.15 Mn
Dec 31, 2016 16.66 Mn
Dec 31, 2016 16.66 Mn
Jun 30, 2016 -3.67 Mn
Jun 30, 2016 -3.67 Mn
Mar 31, 2016 3.67 Mn
Mar 31, 2016 3.67 Mn